Inhibition of AMPK activity by TRIM11 facilitates cell survival of hepatocellular carcinoma under metabolic stress
Open Access
- 17 December 2021
- journal article
- letter
- Published by Wiley in Clinical and Translational Medicine
- Vol. 11 (12) , e617
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31701005, 81874174, 82073190, 81572832)
- Shenzhen Institutes of Advanced Technology Innovation Program for Excellent Young Researchers (201801)
This publication has 10 references indexed in Scilit:
- Metformin Resensitizes Sorafenib-Resistant HCC Cells Through AMPK-Dependent Autophagy ActivationFrontiers in Cell and Developmental Biology, 2021
- TRIM11 activates the proteasome and promotes overall protein degradation by regulating USP14Nature Communications, 2018
- AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic BalanceMolecular Cell, 2017
- Enhanced Degradation of Misfolded Proteins Promotes TumorigenesisCell Reports, 2017
- Autophagy at the crossroads of catabolism and anabolismNature Reviews Molecular Cell Biology, 2015
- Autophagic Cell Death and CancerInternational Journal of Molecular Sciences, 2014
- Prognostic Significance of AMPK Activation and Therapeutic Effects of Metformin in Hepatocellular CarcinomaClinical Cancer Research, 2013
- AMPK: a nutrient and energy sensor that maintains energy homeostasisNature Reviews Molecular Cell Biology, 2012
- The AMPK signalling pathway coordinates cell growth, autophagy and metabolismNature Cell Biology, 2011
- The role of autophagy in cancer development and response to therapyNature Reviews Cancer, 2005